Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Bipolar I Disorder

In brief

The aim of this study is to investigate the efficacy, safety, and tolerability of iloperidone compared with placebo in treating acute manic or mixed episodes associated with Bipolar I Disorder.

Key facts

Study ID
NCT04819776
Run by
Vanda Pharmaceuticals
People needed
417
Starts
2021-03-22
Expected to finish
2023-08-16
Last updated by the study team
2024-04-18

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.